FIGS (FIGS) Expected to Announce Earnings on Thursday

FIGS (NYSE:FIGS) is anticipated to post its Q1 2026 results after the market closes on Thursday, May 7th. Analysts expect FIGS to post earnings of $0.01 per share and revenue of $153.1450 million for the quarter. Interested persons can find conference call details on the company’s upcoming Q1 2026 earning report page for the latest details on the call scheduled for Thursday, May 7, 2026 at 5:00 PM ET.

FIGS (NYSE:FIGS) last posted its quarterly earnings results on Thursday, February 26th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.02 by $0.08. FIGS had a net margin of 5.43% and a return on equity of 8.41%. The company had revenue of $201.90 million for the quarter, compared to analyst estimates of $165.33 million. During the same period in the prior year, the company earned $0.01 earnings per share. The firm’s revenue was up 33.0% on a year-over-year basis. On average, analysts expect FIGS to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

FIGS Stock Up 4.2%

Shares of FIGS traded up $0.59 during mid-day trading on Tuesday, reaching $14.56. The company had a trading volume of 2,538,779 shares, compared to its average volume of 3,280,575. FIGS has a 52-week low of $4.25 and a 52-week high of $17.48. The stock has a market capitalization of $2.42 billion, a P/E ratio of 76.64 and a beta of 1.12. The stock has a 50 day moving average of $14.85 and a two-hundred day moving average of $11.95.

Insiders Place Their Bets

In other FIGS news, CFO Sarah Oughtred sold 22,690 shares of the business’s stock in a transaction that occurred on Thursday, February 5th. The stock was sold at an average price of $10.56, for a total transaction of $239,606.40. Following the completion of the sale, the chief financial officer directly owned 821,500 shares in the company, valued at approximately $8,675,040. The trade was a 2.69% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Catherine Eva Spear sold 62,335 shares of the stock in a transaction that occurred on Thursday, April 2nd. The shares were sold at an average price of $14.44, for a total value of $900,117.40. Following the transaction, the chief executive officer directly owned 1,794,964 shares of the company’s stock, valued at $25,919,280.16. The trade was a 3.36% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 675,098 shares of company stock worth $10,912,375. Company insiders own 29.44% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the company. Marshall Wace LLP lifted its holdings in FIGS by 66.2% in the 4th quarter. Marshall Wace LLP now owns 4,297,868 shares of the company’s stock valued at $48,824,000 after purchasing an additional 1,712,610 shares in the last quarter. BNP Paribas Financial Markets raised its position in shares of FIGS by 2,139.7% in the second quarter. BNP Paribas Financial Markets now owns 1,307,468 shares of the company’s stock valued at $7,374,000 after buying an additional 1,249,091 shares during the last quarter. Ameriprise Financial Inc. raised its position in shares of FIGS by 9.0% in the second quarter. Ameriprise Financial Inc. now owns 13,936,468 shares of the company’s stock valued at $78,602,000 after buying an additional 1,144,962 shares during the last quarter. Squarepoint Ops LLC lifted its stake in shares of FIGS by 940.7% in the second quarter. Squarepoint Ops LLC now owns 924,092 shares of the company’s stock worth $5,212,000 after buying an additional 835,300 shares in the last quarter. Finally, Woodline Partners LP acquired a new position in FIGS during the first quarter worth about $3,199,000. 92.21% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have recently weighed in on FIGS. Weiss Ratings raised shares of FIGS from a “hold (c)” rating to a “hold (c+)” rating in a report on Wednesday, April 29th. Oppenheimer upgraded shares of FIGS from a “market perform” rating to an “outperform” rating and set a $22.00 price target on the stock in a research report on Friday, March 20th. Morgan Stanley lifted their price objective on shares of FIGS from $8.00 to $15.00 and gave the company an “equal weight” rating in a report on Monday, April 13th. Telsey Advisory Group increased their target price on shares of FIGS to $17.00 and gave the stock a “market perform” rating in a research note on Thursday, March 12th. Finally, BTIG Research restated a “buy” rating and set a $20.00 target price on shares of FIGS in a research report on Friday, April 24th. Two investment analysts have rated the stock with a Strong Buy rating, four have given a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $15.93.

FIGS Company Profile

FIGS, Inc operates as a direct-to-consumer designer and retailer of medical apparel and accessories. The company offers a range of products tailored to the needs of healthcare professionals, including scrub sets, lab coats, tops, bottoms, outerwear, footwear, and performance fabrics designed for comfort, durability, and antimicrobial protection. Through its e-commerce platform and a growing network of retail stores, FIGS provides customizable uniforms and accessories with a focus on innovative materials and functional design features such as four-way stretch fabrics, moisture-wicking technology, and multiple secure pockets.

Founded in 2013 by Heather Hasson and Trina Spear, FIGS set out to disrupt the traditional medical uniform market by emphasizing both form and function.